Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_assertion description "[We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulin-dependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_assertion evidence source_evidence_literature NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_assertion SIO_000772 20595388 NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_assertion wasDerivedFrom befree-2016 NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_assertion wasGeneratedBy ECO_0000203 NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.
- befree-2016 importedOn "2016-02-19" NP823016.RAqEabeNLBkNNw_xt_Pdatg_iNj9jYgNycE-2AB1SjcsE130_provenance.